Alkeon Capital Management’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $13.5M | Hold |
|
|||||
|
2025
Q2 | $11.4M | Hold |
|
|||||
|
2025
Q1 | $8.67M | Sell |
|
|||||
|
2024
Q4 | $17.4M | Sell |
|
|||||
|
2024
Q3 | $110M | Buy |
|
|||||
|
2024
Q2 | $73.1M | Hold |
|
|||||
|
2024
Q1 | $106M | Buy |
|
|||||
|
2023
Q4 | $59.6M | Sell |
|
|||||
|
2023
Q3 | $53.4M | Hold |
|
|||||
|
2023
Q2 | $67.4M | Sell |
|
|||||
|
2023
Q1 | $71.7M | Buy |
|
|||||
|
2022
Q4 | $66.9M | Buy |
|
|||||
|
2022
Q3 | $45.5M | Buy |
|
|||||
|
2022
Q2 | $32.5M | Buy |
|
|||||
|
2022
Q1 | $49.3M | Sell |
|
|||||
|
2021
Q4 | $54.2M | Buy |
|
|||||
|
2021
Q3 | $27.7M | Sell |
|
|||||
|
2021
Q2 | $29.9M | Buy |
|
|||||
|
2021
Q1 | $32.2M | Buy |
|
|||||
|
2020
Q4 | $36.8M | Buy |
|
|||||
|
2020
Q3 | $1.16M | Hold |
|
|||||
|
2020
Q2 | $1.13M | Buy |
|